Olympus Korea will discontinue its camera business on June 30 due to low profitability and will shift its focus on medical equipment and science solutions.
The Korean unit of the Japan-headquartered firm that makes optics and photography products will also close its store and online shopping mall next month.
Olympus Korea will keep operating the service facility for repairing and exchanging products until March 31, 2026.
The company tried to improve its profitability with mirrorless cameras and interchangeable lenses, but as South Korea's camera market shrank considerably, it had to withdraw from the business.
Among Olympus Korea's other offerings are endoscopy and surgical equipment and microscopes.
The company has a medical training and education center in Incheon, which it opened in 2017.
Olympus Korea denied that their decision is in support of an ongoing anti-Japan sentiment and boycott all Japanese products in South Korea.


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



